Labcorp Holdings (N6B) Price & Analysis

9 Followers

N6B Stock Chart & Stats

€286.00

€8.00(3.28%)

At close: Jul 24 4:00 PM EDT

€286.00

€8.00(3.28%)

Day’s Range― - ―

52-Week Range€212.00 - €292.00

Previous CloseN/A

Volume0.00

Average Volume (3M)2.00

Market Cap

€21.94B

Enterprise Value€29.60K

Total Cash (Recent Filing)€141.80M

Total Debt (Recent Filing)€6.77B

Price to Earnings (P/E)25.3

Beta0.31

Next Earnings

Oct 28, 2026

EPS Estimate

4.11

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)12.17

Shares Outstanding81,100,000

10 Day Avg. Volume3

30 Day Avg. Volume2

Financial Highlights & Ratios

PEG Ratio1.28

Price to Book (P/B)2.42

Price to Sales (P/S)1.50

P/FCF Ratio17.31

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

€305.64

Price Target Upside6.87% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering13

EPS Forecast (FY)16.13

Revenue Forecast (FY)€12.97B

Bulls Say, Bears Say

Bulls Say

Growth And Margin ExpansionRecent growth is broad enough to support durable earnings improvement: revenue increased, operating margin expanded, and adjusted EPS advanced. If maintained, this combination gives Labcorp more capacity to invest in diagnostics, biopharma services, technology and shareholder returns over the next several quarters.

Biopharma BacklogThe large Biopharma Laboratory Services backlog provides meaningful forward revenue visibility, while book-to-bill above one indicates demand is replenishing delivered work. This supports continued segment growth and helps underpin more predictable utilization and earnings over the coming quarters.

Innovation And PartnershipsNew testing offerings, reimbursement progress and expanded health-system connectivity broaden Labcorp’s commercial reach across consumer, clinical and personalized-care markets. These initiatives can support specialty mix, improve access to testing and create additional durable growth channels beyond routine diagnostics.

Bears Say

Medicare Reimbursement RiskThe preliminary CMS fee schedule creates a material multi-year reimbursement risk for the Diagnostics business. Lower Medicare payment rates could pressure pricing and margins through 2029, while the final impact remains uncertain and may require Labcorp to rely more heavily on volume, mix and efficiency improvements.

Meaningful LeverageAlthough leverage is described as manageable and has improved from 2024, the absolute debt balance remains substantial relative to equity. This reduces financial flexibility, keeps interest and refinancing obligations important, and could constrain acquisitions, investment or shareholder returns if operating conditions weaken.

Margins Below PeakImproved profitability has not restored Labcorp’s earlier margin profile, indicating that earnings quality remains below its prior peak. Sustained margin compression leaves less buffer against reimbursement pressure and operating costs, and makes future earnings growth more dependent on execution and mix improvement.

Labcorp Holdings News

Labcorp reaffirms 2026-2029 long-term outlook announced at Investor Day

In a regulatory filing, the company stated, “On September 21, 2026, the Centers for Medicare & Medicaid Services...

11d ago

Midday Fly By: AutoZone reports Q4 beat, Binance invests in Circle Internet

The major averages were mixed near noon, with the Dow falling almost 300 points but the Nasdaq climbing...

11d ago

Morning Movers: Alibaba jumps after unveiling new AI chip to drive DC buildout

Stock futures were little changed on Tuesday following a rally driven by stocks tied to artificial intelligence. Tuesday’s...

11d ago

AZO

CMS 2027 CLFS proposal skews towards ‘worst end’ for Quest, says Jefferies

After CMS released the preliminary 2027 clinical laboratory fee schedule, concluding that it has overpaid versus commercial market...

11d ago

DGX

CMS announces new preliminary Medicare payment rates for lab services

The Centers for Medicare & Medicaid Services said it plans to better align the 2027 clinical laboratory fee...

12d ago

DGX

Labcorp price target raised to $365 from $350 at Truist

Truist analyst David MacDonald raised the firm’s price target on Labcorp (LH) to $365 from $350 and keeps...

13d ago

Labcorp price target raised to $380 from $361 at UBS

UBS analyst Kevin Caliendo raised the firm’s price target on Labcorp (LH) to $380 from $361 and keeps...

22d ago

Labcorp price target raised to $330 from $320 at Barclays

Barclays raised the firm’s price target on Labcorp (LH) to $330 from $320 and keeps an Equal Weight...

23d ago

Midday Fly By: Macy’s reports ‘beat and raise,’ Nasdaq invests $100M in Payward

The major averages were broadly lower near noon, extending the week’s sharp losses as oil surpassed $100 per...

23d ago

Labcorp provides long-term outlook through 2029

Labcorp (LH) expects to achieve compound annual adjusted EPS growth of 8.5%-11.5% and compound annual revenue growth of...

24d ago

Labcorp to Report Third-Quarter 2026 Financial Results

The latest update is out from Labcorp Holdings ( ($LH) ). Labcorp Holdings Inc., a global leader in...

3d ago

Labcorp Addresses New CMS Lab Fee Schedule Cuts

An update from Labcorp Holdings ( ($LH) ) is now available. Labcorp Holdings said new preliminary Medicare Clinical...

11d ago

Jared Haase Reaffirms Buy on Labcorp, Citing Multi-Pillar Growth Strategy and Achievable Medium-Term Financial Targets

William Blair analyst Jared Haase has reiterated their bullish stance on LH stock, giving a Buy rating today....

23d ago

Labcorp Highlights Growth Strategy at 2026 Investor Day

Labcorp Holdings ( ($LH) ) just unveiled an update. On Sept. 10, 2026, Labcorp hosted its 2026 Investor...

23d ago

N6B FAQ

What was Labcorp Holdings’s price range in the past 12 months?

Labcorp Holdings lowest stock price was €212.00 and its highest was €292.00 in the past 12 months.

What is Labcorp Holdings’s market cap?

Labcorp Holdings’s market cap is €21.94B.

When is Labcorp Holdings’s upcoming earnings report date?

Labcorp Holdings’s upcoming earnings report date is Oct 28, 2026 which is in 25 days.

How were Labcorp Holdings’s earnings last quarter?

Labcorp Holdings released its earnings results on Jul 30, 2026. The company reported €4.405 earnings per share for the quarter, beating the consensus estimate of €4.219 by €0.186.

Is Labcorp Holdings overvalued?

According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Labcorp Holdings pay dividends?

Labcorp Holdings does not currently pay dividends.

What is Labcorp Holdings’s EPS estimate?

Labcorp Holdings’s EPS estimate is 4.11.

How many shares outstanding does Labcorp Holdings have?

Labcorp Holdings has 81,100,000 shares outstanding.

What happened to Labcorp Holdings’s price movement after its last earnings report?

Labcorp Holdings reported an EPS of €4.405 in its last earnings report, beating expectations of €4.219. Following the earnings report the stock price went down -8.088%.

Which hedge fund is a major shareholder of Labcorp Holdings?

Currently, no hedge funds are holding shares in DE:N6B

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Labcorp Holdings Stock Smart Score

Neutral

Fundamentals

Return on Equity

0.92%

Trailing 12-Months

Asset Growth

2.62%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

Labcorp Holdings

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

Labcorp Holdings (N6B) Earnings & Revenues

Historic Earnings Reports

N6B Company Deck

N6B Earnings Call

Q2 2026

0:00 / 0:00

Earnings Call Sentiment|Positive

The call presented a strong operational and financial quarter: revenue growth, margin expansion, double-digit adjusted EPS growth, raised guidance, robust BLS backlog and book-to-bill, and multiple product/partnership launches. Headwinds highlighted were a meaningful quarter-over-quarter drop in free cash flow (timing and capex), a modest ACA-related volume headwind (~30 bps), prior and improving Early Development softness, higher patient-pay mix, and elevated absolute debt with relatively low cash on hand. On balance the positives around revenue, margins, guidance increases, product/market progress, and capital returns materially outweigh the cited challenges.View all DE:N6B earnings summaries

N6B Revenue Breakdown

77.96% Dx

22.21% BLS

-0.16% Intercompany eliminations

N6B Stock 12 Month Forecast

Average Price Target

€305.64

▲(6.87% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"209":"€209","274":"€274","339":"€339","241.5":"€241.5","306.5":"€306.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":338.1204052,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€338.12</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":305.64305049,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€305.64</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":272.27590524,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€272.28</span>\n  </div></div>","useHTML":true}}],"tickPositions":[209,241.5,274,306.5,339],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,274,278.9323388615385,283.8646777230769,288.7970165846154,293.7293554461538,298.6616943076923,303.5940331692308,308.5263720307692,313.4587108923077,318.3910497538461,323.3233886153846,328.2557274769231,333.1880663384615,{"y":338.1204052,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,274,276.4340808069231,278.86816161384615,281.30224242076923,283.7363232276923,286.1704040346154,288.60448484153846,291.03856564846154,293.4726464553846,295.9067272623077,298.3408080692308,300.77488887615385,303.20896968307693,{"y":305.64305049,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,274,273.86737732615387,273.7347546523077,273.60213197846156,273.46950930461537,273.33688663076924,273.20426395692306,273.07164128307693,272.93901860923074,272.8063959353846,272.67377326153843,272.5411505876923,272.4085279138461,{"y":272.27590524,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":239.527,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":215.772,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":226.286,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":210.406,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":222.316,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":242.788,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":226.868,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218.907,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":221.519,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":249.458,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":271.41,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":286,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":274,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >